Clinical Trial Update: Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age [NA]

View source ↗

Summary

The document reports the completion of an efficacy study evaluating the Draeger Jaundice Meter JM-105 for measuring bilirubin in neonates born at ≥24 weeks gest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperbilirubinemia
• Neonatal Jaundice

Drugs mentioned

• Draeger Jaundice Meter JM-105

Snippet

Sponsor: Draeger Medical Systems, Inc. | Conditions: Hyperbilirubinemia, Neonatal Jaundice | NA | Status: COMPLETED